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Biological activity of human mesenchymal stromal
cells on polymeric electrospun scaffolds†
Febriyani F. R. Damanik,a,b Gabriele Spadolini,a,c Joris Rotmans,d Silvia Farè c and
Lorenzo Moroni *a,b
Electrospinning provides a simple robust method to manufacture scaffolds for tissue engineering appli-
cations. Though varieties of materials can be used, optimization and biocompatibility tests are required to
provide functional tissue regeneration. Moreover, many studies are limited to 2D electrospun constructs
rather than 3D templates due to the production of high density packed fibres, which result in poor cell
infiltration. Here, we optimised electrospinning parameters for three different polymers: poly(ε-caprolac-
tone) (PCL), polylactic acid (PLA) and poly(ethylene oxide terephthalate)/poly(butylene terephthalate) (PA)
copolymers. Human mesenchymal stromal cells (hMSCs) were cultured on scaffolds for 14 days to study
the scaffolds’ biocompatibility and their multi-lineage differentiation potential or maintenance of stem-
ness in the absence of chemical stimuli. For all scaffolds, a high and stable metabolic activity was
measured throughout the culture time with a high proliferation rate compared to day 1 (PCL 5.8-, PLA 4-,
PA 4.9-fold). The metabolism of hMSCs was also measured through glucose and lactate concentrations,
showing no cytotoxic levels up to 14 days. Total glycosaminoglycan (GAG) production was the highest in
PA electrospun scaffolds. When normalized to DNA, GAG production was the highest in PLA and PA
scaffolds. All scaffolds were prone to differentiate to an osteogenic lineage, with PCL providing the
highest alkaline phosphatase and collagen type Ia gene upregulation. As PA had the most stable fibre for-
mation, it was chosen as a template to further incorporate stromal cell-derived factor-1 (SDF-1) and gra-
nulocyte colony-stimulating factor (G-CSF), and stimulate higher hMSC infiltration. These scaffolds pro-
vided significantly higher hMSC infiltration than normal PA scaffolds. In conclusion, our optimized bio-
compatible electrospun scaffolds have shown promising regulation of hMSC fate. When combined with
migratory stimulating cytokines, these scaffolds may overcome the known challenges of poor cellular
infiltration typical of micro- and nano-fibrillary random meshes.
1. Introduction
Electrospinning is a robust and simple technique to produce
nanofibres from a wide variety of polymers.1 By controlling
different parameters, electrospinning offers several advan-
tages. These include extremely high surface-to-volume ratio,
tuneable nanofibre composition, porosity, and flexibility to
conform to a wide variety of shapes and sizes.2,3 Hence, elec-
trospun nanofibres have been extensively investigated in the
past decade for their use in various applications, such as fil-
tration, optical and chemical sensors, electrode materials and
scaffolds.4
Human mesenchymal stromal cells (hMSCs) are found
throughout the body and play a crucial role in tissue regener-
ation by migrating to sites of injury and replacing dysfunc-
tional cells via their multipotent differentiation capacity.5
Studies showing short life spans of hMSCs have administered
them without supporting tissues or biocompatible substrates.6
Electrospun scaffolds have been well known to provide a tem-
plate for cells to grow and develop into functional engineered
tissues. This is done by mimicking the natural tissue environ-
ment as the diameter of the electrospun fibres can be tuned to
match the fibrils of the extracellular matrix (ECM).7,8 Cell
behaviour can be quite diverse in response to a scaffold, and
features such as surface topography, chemistry and mechani-
cal properties are known to have an influence on cell activity.9
The mechanical and physical properties of copolymer families
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such as poly(ethylene oxide terephthalate)/poly(butylene tere-
phthalate) (PA) can be easily tailored by varying the PEOT and
PBT weight ratio and the length of the PEG segments,10 and
hence can be a suitable material platform for electrospinning
applications. Moreover, many other biodegradable polymers
such as poly(ε-caprolactone) (PCL) and polylactic acid (PLA)
have been used to obtain electrospun scaffolds that showed
in vitro and in vivo biocompatibility.11,12 However, widespread
success in clinical applications remains dependent on under-
standing the basic cell–scaffold interactions in these nano-
and micro-fibrillar meshes.
A major challenge encountered in electrospinning for
tissue engineering is the heterogeneity of cellular distribution
and migration in the scaffold with increasing depth under
passive, static seeding conditions.13 This can potentially stag-
nate further applications of electrospun scaffolds in various
tissue engineering applications due to the high packing
density of the fibrous network.14 Hence, it is of great impor-
tance to formulate a method to fabricate cell-permeable elec-
trospun scaffolds with enhanced cell distribution and
migration throughout the scaffolds’ volume. Several methods
have reported to address these issues. Decreasing the fibre dia-
meter provided an adverse outcome due to the increase of
fibre-to-fibre contact per unit length, and eventually a decrease
in the mean pore radius.15 Ekaputra et al.16 showed no sig-
nificant improvement upon blending the desired polymer
with a water soluble polymer compared to conventionally
electrospun fibres. The method of leaching out a sacrificial
polymer from an electrospun scaffold is a multiple step
process and might change the chemical and mechanical pro-
perties of the remaining electrospun polymer, ultimately
affecting the cell behaviour.13,17 Another approach consisted
of electrospraying a cellular solution simultaneously with
electrospinning or coaxial electrospinning to encapsulate
cells. However, the complexity of the setup, and additional
exposure of a high electric field and shear stress to the cells,
may limit this approach.18–20
Numerous studies have shown that the chemokine stromal
cell-derived factor-1 (SDF-1) is crucial for stem/progenitor and
mesenchymal cell chemotaxis.21,22 Similarly, granulocyte
colony-stimulating factor (G-CSF) significantly enhances the
homing capacity of these stem cells. In this study, we aimed to
make use of electrospinning to preselect three polymer types
and fine tune their fibre diameter to the same magnitude as
that of the fibrils in the ECM and compare their efficacy as a
substrate for cell growth and distribution. Comparative studies
of PCL, PLA and PA on electrospinning parameters, stem cell
activity and fate have not been explored to this extent. This is
important as many individual studies on PCL, PLA or PA alone
have shown different results. Moreover, gene analysis was per-
formed to display the 3D scaffold potential for hMSC differen-
tiation capacity. Finally, we also combine this cellular analysis
with efforts to solve the well-known cell infiltration issues of
electrospun scaffolds in a straightforward manner. We used a
one-step simple process to improve cell filtration throughout
the scaffold by incorporating chemokines, G-SCF and SDF-1, to
promote hMSC migration and evaluate its functionality
through direct and indirect seeding of loaded scaffolds.
2. Experimental
2.1. Scaffold preparation
Three different polymers were used to electrospun polymeric
fibrous scaffolds: poly(ε-caprolactone) (PCL, Mw = 65 000
Dalton, Sigma Aldrich), polylactic acid (PLA, Mw = 200 000
Dalton, 2002D, Folienwerk Wolfen GmbH) and the copolymer
poly(ethylene oxide terephthalate)/poly(butylene terephthalate)
(PA) (PEG Mw = 300 Dalton, weight ratio 55 : 45 of PEOT : PBT).
Polymer solutions were prepared by dissolution in chloroform
(Sigma Aldrich) overnight at different concentrations within
the range of 10–20% (w/v) (ESI Table 1†). A custom electro-
spinning chamber with environmental control (20 °C, 30%
humidity) was used to fabricate the scaffolds. The prepared
solutions were loaded into a syringe and placed in a syringe
pump (KDS 100, KD Scientific). A metallic needle was con-
nected to a syringe tip that acted as the spinneret. Aluminium
foil was used as a collector. Different flow rates (0.5–20 ml h−1)
and voltages (12–25 kV) were used and examined. Chemokine
incorporation was done with PA scaffolds showing the best
results in terms of flow rate versus control of fibre diameter.
Incorporation of granulocyte colony-stimulating factor and
stromal cell-derived factor (G-CSF, SDF-1; PeproTech) in PA
fibres was performed by mixing the chemokines with 20%
(w/v) polymer solution and electrospinning at 15 kV, 1 ml h−1
flow rate and 20 cm working distance. We used 6 µg ml−1
SDF-1 or G-SCF as the final concentration for electrospinning.
A list of parameter specification for different polymer types
can be seen in ESI Table 1.†
2.2. Scaffold characterisation
Electrospun fibres were gold sputtered (Cressington 108 auto)
at 40 mA and 100 mTorr for 30 seconds. Fibre morphology was
observed using a scanning electron microscope (SEM) (XL 30
ESEM-FEG, Philips/FEI). Images at 50–10000× magnification
were captured and examined for homogeneity and fibre
surface topography. A magnification of 500× was used to
measure the fibre’s diameter. A minimum of 5 images per
sample were randomly acquired with a minimum of 20 fibres
measured to determine fibre diameters using ImageJ (National
Institutes of Health, Bethesda, MD, USA). Selected electro-
spinning parameters were chosen from the highest reproduci-
bility and similar fibre diameters.
2.3. Cell isolation and expansion
Bone marrow aspirates were obtained through written
informed consent, in conformity with national laws and after a
local ethical committee approval. Ethical approval for the use
of bone marrow samples was obtained from the ethical advi-
sory board of the Medisch Spectrum Twente, Enschede. All
methods were carried out in accordance with local and rele-
vant guidelines and regulations. Bone marrow derived
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mesenchymal stromal cells (hMSCs) were isolated and
expanded as previously described.23 hMSCs were cultured in a
culture medium comprising α-MEM (Gibco), fetal bovine
serum (10%, Lonza), ascorbic acid (0.2 mM, Gibco),
L-glutamine (2 mM, Gibco), penicillin (100 U ml−1) and strep-
tomycin (100 mg ml−1, Gibco). hMSCs were expanded at an
initial seeding density of 3000 cells per cm2 in a basic culture
medium and refreshed every 2–3 days. Cells were harvested at
80–90% confluency, before trypsinisation for cell seeding on
electrospun scaffolds. All cell experiments were performed
under a 5% CO2 humid atmosphere at 37 °C.
2.4. In vitro study
In vitro experiments were performed with cells from a 53-year-
old male and seeded at passage 4. PCL, PLA and PA electro-
spun scaffolds 13 mm in diameter and ∼500 µm in thickness
were disinfected in 70% ethanol for 10 minutes 5 times and
the ethanol was allowed to evaporate upon the last incubation.
The scaffolds were then washed twice with sterile PBS (Gibco),
transferred to a non-treated 24 well plate (Nunc) and incubated
in a culture medium overnight. After the removal of the media,
the scaffolds were seeded with 50 000 cells in 250 µl culture
medium. An additional 750 µl culture medium was added
after 4 hours at 37 °C to allow cell attachment. The culture was
observed at day 1, 7 and 14, if not mentioned otherwise.
Loaded PA electrospun scaffolds. Loaded electrospun
scaffolds (diameter = 13 mm) were sterilized with a UV lamp
(UltraLum, Electronic Ultraviolet Crosslinker) at 8.9 mW cm−2
and 254 nm for 30 minutes. The sterilized scaffolds were
placed at the bottom of both normal and transwell (8 µm poly-
carbonate pore size, Corning) plates. For direct seeding of
scaffolds, 50 000 cells per scaffold were used. In transwells,
5000 cells were seeded on top of the transwell membrane. The
culture was observed at day 1 and day 3. The experiments were
performed in triplicate.
2.5. Biochemical assay
Medium analysis: glucose and lactate concentration. At day
5, 10 and 14, 10 µl of the medium from each sample were col-
lected, and glucose and lactate concentrations were measured
on GLU and LAC slides using a Vitros dt60 ii Analyzer
(Johnson & Johnson).
Alamar Blue assay. The samples were washed twice with PBS
and incubated with preheated 1 ml of 1 : 10 Alamar Blue
(Sigma Aldrich) in the culture medium for 4 hours at 37 °C in
the dark. 100 µl of the solution from each sample were
measured in triplicate with a spectrofluorometer at a fluo-
rescence excitation wavelength of 570 nm and emission at
585 nm (Viktor3, PerkinElmer). Fluorescence levels were nor-
malized by cell number to achieve a per cell measurement.
Proliferation and ECM analysis; DNA and glycosaminoglycan
(GAG) assay. The same samples used for Alamar Blue assay
were used for DNA and GAG analysis. The samples were
washed twice with sterile PBS after incubation with Alamar
Blue. The samples were cut, and stored in an Eppendorf tube
at −80 °C until further processing. The samples were then
digested at 56 °C for 16 hours in a Tris-EDTA buffered solution
containing 1 mg ml−1 Proteinase K, 18.5 µg ml−1 pepstatin A
and 1 µg ml−1 iodoacetamide (Sigma Aldrich). DNA quan-
tification was performed following CyQuant DNA assay
(Molecular Probes, Oregon, USA) instructions using a spectro-
fluorometer at 480/520 nm excitation/emission wavelength
(Viktor3, PerkinElmer). Sulphated glycosaminoglycan (sGAG)
content was determined spectrophotometrically with the 9-di-
methylmethylene blue chloride (DMMB, Sigma Aldrich) dye in
PBE buffer (14.2 g l−1 Na2HPO4 and 3.72 g l
−1 Na2EDTA,
pH 6.5) using a microplate reader (Bio-TEK Instruments) at an
absorbance of 520 nm. sGAG levels were normalized by cell
number to achieve a per cell measurement.
Gene expression analysis. Samples were washed twice with
PBS, incubated in Trizol (Invitrogen) and stored at −80 °C
until further processing. Additional chloroform was added to
the thawed samples, which were then vortexed and centrifuged
for 20 minutes at 11 000 rpm at 4° C. The aqueous phase con-
taining RNA was collected, precipitated with 70% ethanol,
transferred to Nucleospin RNA columns (Macherey-Nagel), and
processed following the manufacturer’s instructions. The
quantity and quality of RNA were analysed using an ND100
spectrophotometer at 260 nm (Nanodrop Technologies, USA).
cDNA was synthesized from 500 ng of RNA, using a SensiFast
cDNA synthesis kit (BioRad) according to the manufacturer’s
protocol. Quantitative PCR was performed on an iQ5 detection
system (Bio-Rad) and fold induction was calculated using the
Pfaffl method. The primer sequences are provided in ESI
Table S2.†
Cell migration study. Cytoselect™ Cell Haptotaxis assay (Cell
Biolabs) utilises transwell inserts to assay the migratory pro-
perties of the seeded cells following the manufacturer’s
instruction. Briefly, the inserts were washed with PBS and
gently swabbed to remove non-migratory cells on the top. The
inserts were then stained with the cell staining solution for
10 minutes at room temperature, washed twice with PBS, and
incubated in the extraction solution for 10 minutes on an
orbital shaker. The solution was extracted by using an extrac-
tion buffer and measured with a microplate reader (Bio-TEK
Instruments) at an absorbance of 560 nm.
2.6. Imaging
Inverted light microscope. The stained transwell inserts
from the cell migration study were imaged with 25 ms
exposure for the bottom layer (migratory cells) on a stereo-
microscope at 4× magnification. Image processing was per-
formed to present a black and white contrast view of the inserts.
Live/dead assay. The samples were washed with PBS and
incubated with 6 µM ethidium homodimer and 4 mM calcein
in PBS at 37 °C for 30 minutes in the dark. The images of
green live and red dead cells were acquired by using a fluo-
rescence microscope (Nikon Eclipse E400) with FITC and
Texas-red filters.
Scanning electron microscopy. The samples were washed
with PBS and fixed with 10% formalin for 30 minutes at room
temperature. After rinsing with PBS, the samples underwent
Paper Biomaterials Science
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dehydration steps of 70–80–90–100%, 30 minutes per step.
After dehydration, the PLA and PA samples were critical point
dried (CPD 030 Critical Point Dryer, Leica), while the PCL
samples were dried with hexamethyldisilazane (HMDS, Sigma
Aldrich). Additionally, the samples to study cell migration were
immersed in liquid nitrogen and cut using a sharp blade
along their cross-section. All samples were gold sputtered
(Cressington 108 auto) at 40 mA and 100 mTorr for
30 seconds. The morphology of the cells was observed using a
Philips XL30 ESEM-FEG SEM.
2.7. Statistical analysis
All data are expressed as mean ± s.d. (n = 3), if not stated other-
wise. Biochemical assays were performed in triplicate, if not
stated otherwise. Statistical analysis was performed with two-
way analysis of variance (ANOVA) with Bonferroni’s multiple
comparison test (p < 0.05), unless otherwise indicated in
the figure legends. For all figures the following applies: * =
p < 0.05, ** = p < 0.01, *** = p < 0.001.
3. Results
3.1. Electrospun fibre fabrication from different polymer
solutions and parameters
PCL, PLA and PA at different concentrations were electrospun
with different voltages, working distances and flow rates to fab-
ricate different fibre diameters and surface topographies on
the fibres. Different surface topographies can be obtained on
the scaffolds by tuning the electrospinning parameters. As
seen in Fig. 1a–c, tuning different parameters generated pores
of 10–50 µm size, rough porous surface topographies of fibres,
and bead–string fibres. By controlling the different para-
meters, and allowing only one parameter to change, in this
case the flow rate (Fig. 1g–n), different fibre diameters can be
obtained. By analysing the fibre diameter reproducibility and
similarity, selected electrospinning process parameters
(Table 1) for the different considered polymers were chosen to
prepare the scaffolds for in vitro studies.
3.2. Biocompatibility of electrospun scaffolds through cell
proliferation, viability and morphology
After two weeks of culture, the cells proliferated significantly
(Fig. 2a), resulting in a 5.8-fold increase for PCL, 4-fold for PLA
and 4.9-fold for PA. PCL provided significantly higher prolifer-
ation in comparison with PLA scaffolds. At day 14, the amount
of GAG per scaffold was quantified and showed significantly
higher GAG in PA scaffolds compared to PCL and PLA. When
normalized to the amount of DNA, PA and PLA showed signifi-
cantly higher GAG compared to PCL scaffolds (ESI Fig. 1†).
Cell viability was qualitatively measured by imaging cells using
live/dead staining. As shown in Fig. 2c, the cells observed in
both PCL and PLA scaffolds showed a majority of live cells,
with very limited or no dead cells. Despite the high autofluor-
escence of PA scaffolds, the day 1 inset showed viable live
cells. At day 14, cell viability was confirmed, showing no pres-
ence of dead cells. For all polymer types, cells were homoge-
nously distributed on the scaffolds. SEM images provided a
highly detailed cell morphology (Fig. 2d). In particular, PCL
and PLA scaffolds showed more singular cells and single cell–
fibre contact, while PA substrates displayed more cells, cell–
fibre contact, and cell–cell contact. At day 14, cells formed a
confluent monolayer on the scaffolds with possible ECM
production.
3.3. Metabolic activity analysis on cells seeded on
electrospun scaffolds
The total metabolic activity was observed to increase with the
days of culture (Fig. 3a). A significantly higher metabolic
activity was observed for the PA scaffold in comparison with
PLA at day 1 (Fig. 3b). Moreover, with respect to the amount of
initial glucose, 100 mg dl−1 (11 mmol l−1) in the medium
upon refreshing, around 40% of glucose was consumed from
day 1 to day 5, and significantly more from day 5 to day 10 in
all the considered scaffolds, with cells on PA consuming the
most at 60.33%. There was no significant difference in terms
of glucose consumption at day 14 in comparison with day 10.
In regard to lactate concentration, an average build-up of
27 mg dl−1 (3 mmol l−1) was exhibited at day 5, and a signifi-
cant increase on all scaffold types at day 10 was measured,
with PCL producing the most quantity at 62.6 mg dl−1
(6.95 mmol l−1). No significant difference was observed when
comparing day 10 and 14 lactate production (Fig. 3c). The
amounts of consumed glucose and lactate were normalized by
the amount of cells. A significantly higher glucose consump-
tion was found for PLA with respect to PCL (Fig. 3d).
3.4. Gene expression level on electrospun scaffolds versus
unseeded and tissue culture plates
Considering hMSCs, which were not seeded on electrospun
scaffolds (day 0), as a reference, seeded hMSCs after 14 days of
culture in electrospun scaffolds and tissue culture plates
(TCPs) were downregulated in stemness markers (Fig. 4a). For
both stemness markers, activated leukocyte cell adhesion
molecule (ALCAM) and octamer-binding transcription factor 4
(OCT4), hMSCs on electrospun scaffolds displayed on average
10- and 16-fold downregulation. Both types of downregulation
were statistically significant to TCP of 5- and 7-fold. CD63
was also downregulated by an average of 4-fold, with a slightly
higher expression compared to TCP, although not statisti-
cally significant (Fig. 4a). Comparing differentiation markers,
at day 14 using TCP as a reference (Fig. 4b–g, ESI Fig. 2†) it is
possible to detect the influence of the substrate in hMSC
differentiation. For the osteogenic markers OPN and OCN
(Fig. 4b and c), upregulation was observed for all electrospun
scaffolds with an average of 2- and 7-fold (Fig. 4d). In alkaline
phosphatase (ALP) gene expression, PCL scaffolds provided a
significant upregulation of 4-fold compared to PLA and PA
scaffolds of 2.5- and 3-fold. Collagen type 1a (Col1a) gene
expression also obtained a significantly higher upregulation in
PCL scaffolds of 32-fold, compared to PA (17-fold upregulation)
and PLA (24-fold upregulation) scaffolds (Fig. 4e). For other
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osteogenic markers, such as runt-related transcription factor 2
(Runx2) and bone morphogenetic protein 2 (BMP2), PLA
scaffolds provided a similar gene regulation as TCP in
Runx2 and significantly higher gene regulation than PCL and
PA scaffolds (Fig. 4f and g). For chondrogenic markers, col-
lagen type 2a (Col2a) and sox9 downregulation was observed
Fig. 1 Scanning electron microscopy images of electrospun fibres and fibre diameter analysis. (a–f ) Images of PCL, PLA and PA. (a–c) Different
surface topographies created by electrospinning: (a) semi-rough circular pores, (b) rough porous fibres, and (c) beads and strings. (d–f ) Fibres rep-
resented in Table 1, providing different parameters to fabricate similar diameter fibres of different polymer compositions. (g–l) Images of PA at
different flow rates: (g) 1, (h) 2.5, (i) 5, ( j) 10, (k) 15, and (l) 20 ml h−1. Scale bar: 50 µm. (m) The correlation between fibre diameter and flow rate
upon electrospinning PCL, PLA and PA solutions. All data are shown as mean ± s.d. (n = 20).
Table 1 Selected parameters representing high reproducibility and similar fibre diameters for cell culture studies
Polymer Concentration (w/v) Voltage Working distance Flow rate Fibre diameter
PCL 20% 12 kV 20 cm 0.8 ml h−1 4.387 ± 0.567 µm
PLA 15% 12 kV 20 cm 7.5 ml h−1 4.504 ± 1.064 µm
PA 20% 15 kV 20 cm 1.0 ml h−1 6.313 ± 1.004 µm
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when compared to TCP. PLA scaffolds exhibited a lower down-
regulation of 2-fold, significantly lower than PA scaffolds in
Col2a gene expression (ESI Fig. 2†).
3.5. Stimulating active migration of hMSCs to the depth of
the electrospun scaffold
As PA showed more homogeneous retention of fibre mor-
phology with a fibre diameter increasing with increasing
flow rate up to 20 ml h−1, we chose these conditions to electro-
spin scaffolds incorporating G-CSF and SDF-1 to induce the
migration of hMSCs to the inner part of the electrospun
scaffolds. As reported in Fig. 5a–c, normal PA scaffolds did not
provide a high amount of cell filtration despite the high cell
density on the top surface. By incorporating G-SCF and SDF-1
chemokines, cell filtration increased significantly (Fig. 5d–i).
Dual layer scaffolds, where fibres loaded with G-SCF or SDF-1
chemokines are found on the bottom layer of the scaffolds,
actively attracted hMSCs to infiltrate to the bottom layer of the
scaffolds (Fig. 5j–o). Fig. 5p shows that PA with G-SCF and
SDF-1 chemokines tended to have a higher metabolic activity
compared to PA only. Direct contact of hMSCs with PA loaded
with chemokines resulted in a higher significant difference
compared to PA only upon initial seeding. At day 3, PA + SDF-1
provided a significant higher metabolic activity. Direct contact
with PA + G-CSF showed a significantly higher metabolic
activity in comparison with PA/G-SCF at day 1. This was also
observed for SDF-1 at day 3, with a slightly higher metabolic
activity for PA + G-CSF in comparison with PA/G-SCF. Cell
migration studies (Fig. 5q) using transwell membranes showed
a significant increase of migratory cells when PA scaffolds were
loaded with G-SCF and SDF-1 chemokines, with PA mixed with
chemokines being more statistically significant than PA with
an additional layer of chemokines. Furthermore, the stained
images of migratory cells supported our results demonstrating
that loaded scaffolds induced more hMSC migration (ESI
Fig. 3†).
4. Discussion
Here, we used three different polymers to electrospin scaffolds
mimicking the physical structure of the natural tissue environ-
Fig. 2 In vitro analysis of cell proliferation, viability and morphology. (a) Total number of cells attached to the scaffold at day 1 and 14. (b) Amount
of GAG produced per scaffold at day 14 (n = 6). Statistical analysis was performed with one-way analysis of variance (ANOVA) with Bonferroni’s mul-
tiple comparison test (p < 0.05). For all, blue stars (*P < 0.05, **P < 0.01, ***P < 0.001) indicate statistically significant values comparing the different
time points, while black stars compare each scaffold type to one another. (c) Live/dead staining qualitatively measures the amount of live and dead
cells found in the scaffold at day 1 and 14. Due to the high auto-fluorescence of PA at day 1, an inset at a higher magnification was provided to help
visualize the ratio between live and dead cells. Scale bar: 100 µm. (d) SEM images of cell morphology at day 1 and day 14 for distribution. Red arrows
indicate cell’s location. Scale bar at day 1: 50 µm; day 14: 500 µm.
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ment by fine tuning different processing parameters. By con-
trolling the different parameters of electrospinning, such as
solution concentration and composition, voltage, working dis-
tance, flow rate, humidity and temperature, one can tune the
resulting fibre diameter and topography.2 This versatility can
provide many solutions for various applications.4,17 A standard
control to check if electrospinning produces high-quality
fibres would be to evaluate if the fibres are distinguishable,
smooth and without beads. However, non-standard fibres
(Fig. 1a–c) can eventually provide alternative applications. The
creation of circular pores has been shown to provide higher
cell attachment and increase ECM protein secretion.24 Porous
fibre surfaces increased focal adhesion strength and have been
shown to contribute to hMSC differentiation to osteogenic
lineages through the activation of ERK 1/2 by the Grb2-Sos-Ras
pathway.25,26 Moreover, beads can be used as a drug reservoir
and have diverse applications in controlled drug delivery.27
Fibre diameters of about 5 µm were chosen to mimic a similar
magnitude of native fibrils and provide an optimal template
for cells to attach and distribute well around the fibres with
diameters smaller than those of the cells.28 Increasing flow
rate resulted in an increase of the fibre diameter, which is sup-
ported by many other studies with other polymers.2 When
spinning different polymer compositions, tuning the different
parameters might be necessary to provide similar fibre dia-
meters. Different polymers have different molecular weights
and chemical compositions, which reflect the number of
entanglement and the type of polymer chain in the solution.
This has a significant effect on rheological and electrical pro-
perties such as viscosity, surface tension, conductivity and
dielectric strength,3 which are important for the morphology
of the electrospun fibres, hence resulting in differences in the
fibre diameter despite similar flow rates.
In tissue engineering applications, fibrous electrospun
scaffolds require an optimal template for cells to seed,
migrate, and grow. Successful regeneration of biological
tissues and organs calls for the development of fibrous struc-
tures with fibre architectures beneficial for cell deposition and
proliferation. Here, we demonstrated how our scaffolds pro-
duced a high proliferation rate up to 6-fold higher after two
weeks of culture, and provided good distribution of the cells
and high cell confluency. PCL scaffolds displayed the highest
increase in proliferation with significantly higher cell attach-
ment at day 14 compared to PLA. However, PLA showed higher
initial cell attachment. This could be due to the relatively
higher hydrophilicity of the PLA used here compared to PCL,
in addition to its lower molecular weight.29,30 PLA has been
known to degrade through bulk hydrolysis of ester bonds
releasing lactic acid. This may cause a drop in pH levels and
increase ionic strength by releasing lactate ions that might
Fig. 3 Cell metabolism on electrospun scaffolds. (a–b) Alamar Blue assay was performed on the three considered scaffolds for day 1, 7 and 14.
Total metabolic activity significantly increased on all scaffold types from day 1 to day 7, and to day 14. Single cellular metabolism was similar on day
1 and 14, with a significant higher metabolic activity for the PA scaffold at day 1. (c) Amount of glucose (left y axis; continuous line) and lactate (right
y axis; ticks) found in the culture medium at day 5, 10, and 14. Black, blue and red stars at day 10 represent the colour bar of PCL, PLA and PA,
respectively, indicating a significant increase or decrease in concentration compared to day 5. (d) Consumption of glucose and lactate was normal-
ized to the number of cells at day 14, showing significantly higher glucose consumption on PLA compared to PCL. Statistical analysis was done with
one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparison test (p < 0.05). With exception to (c), blue stars (*P < 0.05, **P < 0.01,
***P < 0.001) indicate statistically significant values in comparison with different time points, while black stars compare each scaffold type to one
another.
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hamper cell proliferation.31 Hence, despite being more hydro-
philic than PCL, PLA provided lower proliferation at day 14.
Upon encountering hydrophobic surfaces such as PA, the cells
were prone to aggregate and trigger the production of ECM
proteins such as GAG and collagen.32 Moreover, PA has been
shown to be more hydrophobic compared to the other con-
sidered polymer types.24 This could explain the necessity of
cell–cell contact, and higher secretion of total GAG, as the cells
seem to be more grouped and less spread compared to PLA
and PCL.
One of the key factors of biocompatibility of an implanted
biomaterial is cell viability and metabolic activity. Here, we
showed that cells are viable in our electrospun scaffolds, with
a majority of live cells and limited or no dead cells. Alamar
Blue assay33 supported these findings showing a significantly
high increase of metabolic activity throughout the culture
time, and a stable activity when normalised to the number of
cells. Initially, significantly higher metabolic activity was seen
in PA in comparison with PLA scaffolds, perhaps due to the
higher hydrophobicity of the scaffold providing the need to
secrete proper proteins for optimal adherence. In recent
studies, a higher amount of the ECM, which can be correlated
to higher metabolic activity, was produced in less hydrophilic
surfaces to maintain a more optimal environment for the cells
to grow.24 Another factor to evaluate cell/scaffold interaction
would be the concentration of glucose and lactate. Cells utilize
glucose available in the culture medium (100 mg dl−1) for
energy and produce lactate as a metabolic by-product. High
levels of lactate (≥20 mmol L−1) can significantly inhibit cell
growth.31 Hence, monitoring glucose and lactate concen-
trations is a crucial assessment for culture performance. As the
medium was refreshed at day 1, 5, 7, and 10, we show a high
metabolism of glucose with a significant increase at day 10
and 14 compared to day 5. The metabolic waste lactate was at
a level not considered to be cytotoxic.34 However, increased
levels of lactate likely due to the degradation of PLA in combi-
nation with a reduced pH may hamper cell growth. A possible
explanation to the medium analysis at day 14 normalized by
cell amount, with PLA providing a significantly higher glucose
consumption, reflects and supports the analysed cell meta-
bolic activity.
hMSCs are often used in tissue engineering strategies
because of their ability to differentiate into multiple cell
lineages.35,36 Li et al. found that electrospun PCL scaffolds
support the attachment, proliferation and differentiation of
hMSCs into adipogenic, chondrogenic, or osteogenic lineages
based upon the culture media selected.37 Here, we used a
basic medium to examine the potential of MSC differentiation
Fig. 4 Gene expression of hMSCs on the electrospun scaffold for its potential to retain stemness and multilineage skeletal differentiation. (a)
hMSCs seeded on a tissue culture plate (TCP) for 14 days were used as the control, while unseeded scaffolds (day 0) were used as a reference and
normalized to electrospun scaffolds and the control. All electrospun scaffolds showed downregulation of the stemness markers CD63, OCT4 and
ALCAM. (b–g) hMSCs seeded on a TCP for 14 days were used as a reference and normalized to electrospun scaffolds. The osteogenic markers OCN,
OPN, ALP and Col1a showed upregulation on electrospun scaffolds, while the Runx2 and BMP2 gene expression was downregulated for PCL and PA
scaffolds. Statistical analysis was done with one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparison test (p < 0.05). For all, blue
stars (*P < 0.05, **P < 0.01, ***P < 0.001) indicate statistically significant values in comparison with the control at day 14, while black stars compare
each scaffold type to one another.
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Fig. 5 Active triggering of the migration of hMSCs by incorporation of chemokines. The “+” symbol represents a mixture of PA and chemokines
(SDF-1 or G-SCF), while “/” divides the two layers of PA at the top and PA mixed with chemokines on the bottom. (a–c) SEM images of PA without
chemokines (PA), (d–f ) PA incorporated with G-SCF (PA + G-SCF), (g–i) PA incorporated with SDF-1 (PA + SDF-1), ( j–o) Dual layer scaffolds with a
top layer of PA only and a bottom layer of PA + G-SCF (PA/G-SCF), or PA + SDF-1 (PA/SDF-1). Red arrow displays the location of cells inside the
scaffold. (a, d, g, j, m) Combined top view where the scaffolds were at first in contact with seeded hMSCs; (b, e, h, k, n) cross-section view to reveal
potential cell migration into the depth of scaffolds; and (c, f, i, l, o) higher magnification view to show the features of the migrated cells. As shown,
PA scaffolds with chemokines supported more migratory cells than PA scaffolds alone. Dual layer scaffolds showed very few cells on the top layer
and many in the bottom layer with chemokines. Scale bar: 100 µm. (r) Metabolic activity of cells seeded on the top of the scaffolds with or without
chemokines, and dual layer scaffolds. (s) In a transwell study with no direct cell contact with the scaffolds, migratory cells were quantified and dis-
played in optical density absorbance for PA with or without chemokines, and dual layer scaffolds. Black stars (*P < 0.05, **P < 0.01, ***P < 0.001)
compare each scaffold type to one another while red stars compare each scaffold to the control (PA).
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and stemness maintenance of three different chemical compo-
sition polymeric scaffolds, without the addition of differen-
tiation supplements. SB-10 antibody, a surface marker of
CFU-Fs, reacts with CD166 (also known as ALCAM) found on
undifferentiated MSCs, which disappears as soon as the cells
initiate osteogenic differentiation and start to secrete alkaline
phosphatase on their cell surface.38 This could be the reason
why all scaffolds downregulated stemness markers, as all
seemed to be prone to differentiate to an osteogenic lineage.
High porosity surfaces, as the one obtained in electrospinning,
can influence a number of cellular processes.39 A previous
study showed that the disordered array of pores resulted in an
increase in bone mineral production and osteogenic differen-
tiation of hMSCs even in the absence of chemical sup-
plements.40 Similarly, Kumar et al. showed that the cells are
highly sensitive to the scaffold structure with nanofibrous
scaffolds, which steered hMSCs down to an osteogenic
lineage.41 Moreover, studies comparing 2D and 3D scaffolds
showed a higher level of osteoblast proliferation and could be
favourable for bone matrix formation.42
The potential of osteogenic differentiation was detected in
all our electrospun scaffolds, with the upregulation of ALP,
Col1a, OPN and OCN. Osteogenic differentiation of MSCs
in vitro can be divided into three stages. The first stage consists
of an initial proliferation period, confluency and expression of
Runx2 and BMP2.43 Runx2, the earliest transcription factor
proven to be essential for bone formation, is activated by DLX3
and a homeodomain transcriptional network through BMP2.44
The second stage is early cell differentiation, which is charac-
terised by the expression of the ALP and Col1 matrix providing
a template where the minerals will be deposited.45,46 The final
stage is the high expression of OCN and OPN, followed by
calcium and phosphate deposition.47 Studies of early markers
of osteogenic differentiation are normally performed after
three days in culture, between the proliferation stage and the
determined stage of differentiation due to their high
expression.48,49 Hence, despite the crucial activation of Runx2
to promote ALP, Col1a, OPN and OCN, high expression of
these late markers was not seen at day 14. Furthermore, studies
have found that short-term BMP-2 treatment is both necessary
and sufficient for osteogenic differentiation.50 PCL provided the
highest upregulation of ALP and Col1a. Col1a is a general
marker of production of the ECM, which could also explain the
highest proliferation rate on PCL. Hydrophilic surfaces tend to
enhance early osteogenic markers, such as ALP and Col1a, com-
pared to hydrophobic surfaces,51,52 much like that seen when
comparing PCL to PA scaffolds. From this theory, PLA scaffolds
might have provided a higher upregulation; however one could
argue that the degradation of the PLA scaffolds, and the release
and chemical actions of lactic ions hampers upregulation,53 as
the addition of a decreased pH has been shown to significantly
decrease ALP activity and collagen synthesis.54,55
hMSCs can undergo osteoblastic differentiation in response
to nanoscale surface features of pits, grooves, symmetry and
disorder in absence of media supplements.40,56 Dalby et al.
showed that the differentiation mechanism of these cells was
different compared to the cells cultured in media sup-
plemented with dexamethasone, despite having similar gene
expressions.57 The physical and mechanical properties of the
scaffolds did not stimulate chondrogenic differentiation to the
same level as shown in the literature.58,59 PLA might provide a
potential scaffold for cartilage regeneration, due to its high
GAG/DNA and highest gene expression of the Col2a and
Sox9 markers, compared to PCL and PA. However, much needs
to be modified in the PLA scaffold alone and recent studies
have combined PLA with carbon nanotubes, gelatin, collagen,
and chitosan to create scaffolds for cartilage regeneration.60,61
For future studies, differentiation media could be used as posi-
tive controls, such as the addition of a basic fibroblast growth
factor to maintain stemness,62 dexamethasone (DEX) and
beta-glycerophosphate to differentiate to osteogenic
lineages63,64 and transforming growth factor-beta for a chon-
drogenic medium.65,66
For the development of electrospun scaffolds for tissue
engineering applications, one would need to consider the
ability of cells to infiltrate into the pore network. Many electro-
spun scaffolds provide high cell proliferation, but are some-
what limited to their outside part as the cells are not able to
infiltrate their pore network.13 Several studies have been
focused to improve cell infiltration. However, they have shown
very limited improvement or adverse response in other func-
tionalities of electrospun scaffolds at the interface with
cells.16,67,68 Other novel ways to improve cell filtrations would
normally require limiting the variety of polymers that can be
electrospun, post-processing, and eliminating the simplicity of
electrospinning by adding complex setups.13,67,69 Cells can
migrate in response to a variety of chemical and physical
stimuli. Hence, in this study we used a one-step electro-
spinning technique by incorporating chemokines, SDF-1 or
G-SCF to promote hMSC migration into the depth of the
scaffold. PA was the scaffold of choice due to its ability to be
electrospun at different flow rates resulting in fine fibres, with
increasing fibre diameter. Moreover, the high molecular
weight of PA allows it to maintain a sufficient number of
entanglements of the polymer chains, hence ensuring a
sufficient level of solution viscosity to yield a uniform jet
during electrospinning and restrain effects of surface tension,
which plays a major role in bead formation.70 Despite this, PA
loaded scaffolds resulted in bead formations on the fibres.
Although this might be considered as a hindrance, it could
actually serve as an advantage of visualizing the intersection
between the layer of PA only fibres and PA loaded fibres for
double layer PA scaffolds. As mentioned before,27 beads can be
used as drug reservoirs of SDF-1 and G-SCF and provide an
explanation on such a significant effect on migration in both
single and double layer PA scaffolds on both direct and trans-
well types of seeding. Furthermore, Gaharwar et al. showed
that the encapsulation of dexamethasone within the beaded
structure resulted in sustained release of the drug over a
period of 28 days.71 In spite of the improvement of cellular
infiltration, the presence of a bead is a distortion of the orig-
inal shape of the scaffold, possibly changing its mechanical
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properties, resulting in a change of the cellular behaviour.
Moreover, one could argue that physical changes through the
presence of beads resulting in a smaller fibre diameter, but a
similar if not higher porosity, could be the reason for higher
cellular infiltration regardless of the chemokines present.
Nevertheless, Zander et al. used sacrificial layers in a PEO com-
bined PCL scaffold, but no difference was observed in cellular
infiltration possibly due to the bead or cluster formation of
PEO fibres. Here, we observed bead formation, yet with suc-
cessful cell migration into the scaffold. Other methods can be
used to avoid bead formation during electrospinning, such as
adjusting the different parameter setups, as well as adding a
salt to improve the charge carrying capacity of the solution
creating bead-free fibres.72 Exposing hMSCs to G-CSF can sig-
nificantly enhance the homing capacity of these stem cells
towards SDF-1.73 Further studies can be envisioned to engineer
a dual incorporation of G-SCF and SDF-1 into the electrospun
scaffolds. Moreover, SDF-1 and G-SCF have been known not
only to promote hMSC migration but also angiogenesis and
revascularization of the tissue.74,75 Hence, this strategy would
provide a promising template for many tissue engineering
applications.
5. Conclusion
Electrospinning is indeed a notable and convenient way to fab-
ricate scaffolds for tissue engineering purposes. Optimization
of electrospinning is crucial to provide a biocompatible, elec-
trospun mimicking ECM with proper infiltration for successful
tissue regeneration, without reducing its original simplicity.
Our study optimised three different polymers, PCL, PLA and
PA, and investigated their biocompatibility showing high
and stable metabolic activity and proliferation, viable cells,
and modulation of glucose and lactate concentrations. The
scaffolds showed potential in stimulating cells toward osteo-
genic lineage with PCL providing most early osteogenic
upregulation and PLA early chondrogenesis. We introduced a
one-step electrospinning technique using the stable fibre pro-
ducing PA scaffolds to incorporate the chemokines G-SCF and
SDF-1 to enhance hMSC infiltration and proved through cell
migratory studies their significant potential in improving
cellular infiltration. In conclusion, this study has provided a
potential and simple way to overcome the challenges in cellular
infiltration in highly packed dense electrospun scaffolds for 3D
tissue regeneration.
Conflicts of interest
There are no conflicts to declare.
Acknowledgements
This research forms part of the Project P3.03 DialysisXS of the
research program of the BioMedical Materials Institute,
co-funded by the Dutch Ministry of Economic Affairs,
Agriculture and Innovation. The financial contribution of the
Nierstichting Nederland is gratefully acknowledged. This
research project has been made possible with the support of
the Dutch Province of Limburg.
References
1 D. H. Reneker and I. Chun, Nanotechnology, 1996, 7, 216–
223.
2 J. M. Deitzel, J. Kleinmeyer, D. Harris and N. C. Beck Tan,
Polymer, 2001, 42, 261–272.
3 A. K. Haghi and M. Akbari, Phys. Status Solidi A, 2007, 204,
1830–1834.
4 Z. M. Huang, Y. Z. Zhang, M. Kotaki and S. Ramakrishna,
Compos. Sci. Technol., 2003, 63, 2223–2253.
5 E. Eggenhofer, F. Luk, M. H. Dahlke and M. J. Hoogduijn,
Front. Immunol., 2014, 5, 148.
6 E. Eggenhofer, V. Benseler, A. Kroemer, F. C. Popp,
E. K. Geissler, H. J. Schlitt, C. C. Baan, M. H. Dahlke and
M. J. Hoogduijn, Front. Immunol., 2012, 3, 297.
7 W. Cui, Y. Zhou and J. Chang, Sci. Technol. Adv. Mater.,
2010, 11, 014108.
8 W. Friess, Eur. J. Pharm. Biopharm., 1998, 45, 113–136.
9 N. G. Rim, C. S. Shin and H. Shin, Biomed. Mater., 2013, 8,
014102.
10 L. Moroni, J. R. de Wijn and C. A. van Blitterswijk,
J. Biomed. Mater. Res., Part A, 2005, 75, 957–965.
11 M. A. Woodruff and D. W. Hutmacher, Prog. Polym. Sci.,
2010, 35, 1217–1256.
12 D. Garlotta, J. Polym. Environ., 2001, 9, 63–84.
13 S. Khorshidi, A. Solouk, H. Mirzadeh, S. Mazinani,
J. M. Lagaron, S. Sharifi and S. Ramakrishna, J. Tissue Eng.
Regener. Med., 2016, 10, 715–738.
14 B. A. Blakeney, A. Tambralli, J. M. Anderson, A. Andukuri,
D. J. Lim, D. R. Dean and H. W. Jun, Biomaterials, 2011, 32,
1583–1590.
15 S. J. Eichhorn and W. W. Sampson, J. R. Soc., Interface,
2005, 2, 309–318.
16 A. K. Ekaputra, G. D. Prestwich, S. M. Cool and
D. W. Hutmacher, Biomacromolecules, 2008, 9, 2097–
2103.
17 B. M. Baker, A. O. Gee, R. B. Metter, A. S. Nathan,
R. A. Marklein, J. A. Burdick and R. L. Mauck, Biomaterials,
2008, 29, 2348–2358.
18 M. F. Canbolat, C. Tang, S. H. Bernacki, B. Pourdeyhimi
and S. Khan, Macromol. Biosci., 2011, 11, 1346–1356.
19 J. T. Seil and T. J. Webster, Int. J. Nanomed., 2011, 6, 1095–
1099.
20 A. Townsend-Nicholson and S. N. Jayasinghe,
Biomacromolecules, 2006, 7, 3364–3369.
21 X. Liu, B. Duan, Z. Cheng, X. Jia, L. Mao, H. Fu, Y. Che,
L. Ou, L. Liu and D. Kong, Protein Cell, 2011, 2, 845–
854.
22 Y. Wu and R. C. Zhao, Stem Cell Rev., 2012, 8, 243–250.
Paper Biomaterials Science
1098 | Biomater. Sci., 2019, 7, 1088–1100 This journal is © The Royal Society of Chemistry 2019
Pu
bl
is
he
d 
on
 2
1 
D
ec
em
be
r 
20
18
. D
ow
nl
oa
de
d 
on
 1
0/
9/
20
20
 1
0:
40
:0
4 
A
M
. 
View Article Online
23 S. K. Both, A. J. C. v. d. Muijsenberg, C. A. v. Blitterswijk,
J. d. Boer and J. D. d. Bruijn, Tissue Eng., 2007, 13, 3–9.
24 F. F. Damanik, T. C. Rothuizen, C. van Blitterswijk,
J. I. Rotmans and L. Moroni, Sci. Rep., 2014, 4, 6325.
25 S. Lavenus, M. Berreur, V. Trichet, P. Pilet, G. Louarn and
P. Layrolle, Eur. Cells Mater., 2011, 22, 84–96; discussion
96.
26 M. J. Biggs and M. J. Dalby, Proc. Inst. Mech. Eng., Part H,
2010, 224, 1441–1453.
27 H. Qi, P. Hu, J. Xu and A. Wang, Biomacromolecules, 2006,
7, 2327–2330.
28 C. T. Laurencin, A. M. Ambrosio, M. D. Borden and
J. A. Cooper Jr., Annu. Rev. Biomed. Eng., 1999, 1, 19–46.
29 F. Ahmed and D. E. Discher, J. Controlled Release, 2004, 96,
37–53.
30 E. Suihko, R. T. Forbes, O. Korhonen, J. Ketolainen,
P. Paronen, J. Gynther and A. Poso, J. Pharm. Sci., 2005, 94,
745–758.
31 Y. He, W. Wang and J. Ding, Chin. Sci. Bull., 2013, 58,
2404–2411.
32 S. Sart, A. C. Tsai, Y. Li and T. Ma, Tissue Eng., Part B, 2014,
20, 365–380.
33 S. N. Rampersad, Sensors, 2012, 12, 12347–12360.
34 T. Omasa, K. Higashiyama, S. Shioya and K. Suga,
Biotechnol. Bioeng., 1992, 39, 556–564.
35 S. Ghoraishizadeh, A. Ghorishizadeh, P. Ghoraishizadeh,
N. Daneshvar and M. H. Boroojerdi, Adv. Regener. Med.,
2014, 2014, 1–14.
36 D. Howard, L. D. Buttery, K. M. Shakesheff and
S. J. Roberts, J. Anat., 2008, 213, 66–72.
37 W. J. Li, R. Tuli, X. Huang, P. Laquerriere and R. S. Tuan,
Biomaterials, 2005, 26, 5158–5166.
38 K. Kaveh, R. Ibrahim, B. M. Zuki Abu and T. Azmi Ibrah,
J. Anim. Vet. Adv., 2011, 10, 2317–2330.
39 J. L. Ifkovits, K. Wu, R. L. Mauck and J. A. Burdick, PLoS
One, 2010, 5, e15717.
40 M. J. Dalby, N. Gadegaard, R. Tare, A. Andar, M. O. Riehle,
P. Herzyk, C. D. Wilkinson and R. O. Oreffo, Nat. Mater.,
2007, 6, 997–1003.
41 G. Kumar, C. K. Tison, K. Chatterjee, P. S. Pine,
J. H. McDaniel, M. L. Salit, M. F. Young and C. G. Simon
Jr., Biomaterials, 2011, 32, 9188–9196.
42 X. F. Tian, B. C. Heng, Z. Ge, K. Lu, A. J. Rufaihah,
V. T. Fan, J. F. Yeo and T. Cao, Scand. J. Clin. Lab. Invest.,
2008, 68, 58–67.
43 A. Neve, A. Corrado and F. P. Cantatore, Cell Tissue Res.,
2011, 343, 289–302.
44 M. Q. Hassan, R. S. Tare, S. H. Lee, M. Mandeville,
M. I. Morasso, A. Javed, A. J. van Wijnen, J. L. Stein,
G. S. Stein and J. B. Lian, J. Biol. Chem., 2006, 281, 40515–
40526.
45 L. D. Quarles, D. A. Yohay, L. W. Lever, R. Caton and
R. J. Wenstrup, J. Bone Miner. Res., 1992, 7, 683–692.
46 J. E. Aubin, Rev. Endocr. Metab. Disord., 2001, 2, 81–94.
47 Z. Huang, E. R. Nelson, R. L. Smith and S. B. Goodman,
Tissue Eng., 2007, 13, 2311–2320.
48 N. Logan and P. Brett, Stem Cells Int., 2013, 2013,
361637.
49 S. Watari, K. Hayashi, J. A. Wood, P. Russell, P. F. Nealey,
C. J. Murphy and D. C. Genetos, Biomaterials, 2012, 33,
128–136.
50 D. Noel, D. Gazit, C. Bouquet, F. Apparailly, C. Bony,
P. Plence, V. Millet, G. Turgeman, M. Perricaudet, J. Sany
and C. Jorgensen, Stem Cells, 2004, 22, 74–85.
51 J. M. Curran, Z. Tang and J. A. Hunt, J. Biomed. Mater. Res.,
Part A, 2009, 89, 1–12.
52 J. Fan, H. Park, S. Tan and M. Lee, PLoS One, 2013, 8,
e72474.
53 T. Chen, Y. Zhou and W. S. Tan, Cell Biol. Toxicol., 2009, 25,
573–586.
54 D. H. Kohn, M. Sarmadi, J. I. Helman and P. H. Krebsbach,
J. Biomed. Mater. Res., 2002, 60, 292–299.
55 T. Okabe, M. Sakamoto, H. Takeuchi and K. Matsushima,
J. Endod., 2006, 32, 198–201.
56 M. J. Dalby, D. McCloy, M. Robertson, C. D. Wilkinson and
R. O. Oreffo, Biomaterials, 2006, 27, 1306–1315.
57 M. J. Dalby, A. Andar, A. Nag, S. Affrossman, R. Tare,
S. McFarlane and R. O. Oreffo, J. R. Soc., Interface, 2008, 5,
1055–1065.
58 H. Mahboudi, B. Kazemi, M. Soleimani, H. Hanaee-Ahvaz,
H. Ghanbarian, M. Bandehpour, S. E. Enderami,
M. Kehtari and G. Barati, Gene, 2018, 643, 98–
106.
59 A. Di Luca, K. Szlazak, I. Lorenzo-Moldero, C. A. Ghebes,
A. Lepedda, W. Swieszkowski, C. Van Blitterswijk and
L. Moroni, Acta Biomater., 2016, 36, 210–219.
60 A.-M. Haaparanta, E. Järvinen, I. F. Cengiz, V. Ellä,
H. T. Kokkonen, I. Kiviranta and M. Kellomäki, J. Mater.
Sci.: Mater. Med., 2013, 25, 1129–1136.
61 J. Markowski, A. Magiera, M. Lesiak, A. L. Sieron, J. Pilch
and S. Blazewicz, J. Nanomater., 2015, 2015, 1–9.
62 J. Wu, G. T. Huang, W. He, P. Wang, Z. Tong, Q. Jia,
L. Dong, Z. Niu and L. Ni, J. Endod., 2012, 38, 614–622.
63 L. Kyllonen, S. Haimi, B. Mannerstrom, H. Huhtala,
K. M. Rajala, H. Skottman, G. K. Sandor and S. Miettinen,
Stem Cell Res. Ther., 2013, 4, 17.
64 N. Jaiswal, S. E. Haynesworth, A. I. Caplan and S. P. Bruder,
J. Cell. Biochem., 1997, 64, 295–312.
65 L. A. Solchaga, K. J. Penick and J. F. Welter, Methods Mol.
Biol., 2011, 698, 253–278.
66 W. J. Li, R. Tuli, C. Okafor, A. Derfoul, K. G. Danielson,
D. J. Hall and R. S. Tuan, Biomaterials, 2005, 26, 599–609.
67 X. Xu, J. F. Zhang and Y. Fan, Biomacromolecules, 2010, 11,
2283–2289.
68 N. E. Zander, J. A. Orlicki, A. M. Rawlett and T. P. Beebe,
J. Mater. Sci.: Mater. Med., 2012, 24, 179–187.
69 K. Tuzlakoglu, M. I. Santos, N. Neves and R. L. Reis, Tissue
Eng., Part A, 2011, 17, 463–473.
70 N. Bhardwaj and S. C. Kundu, Biotechnol. Adv., 2010, 28,
325–347.
71 A. K. Gaharwar, S. M. Mihaila, A. A. Kulkarni, A. Patel, A. Di
Luca, R. L. Reis, M. E. Gomes, C. van Blitterswijk,
Biomaterials Science Paper
This journal is © The Royal Society of Chemistry 2019 Biomater. Sci., 2019, 7, 1088–1100 | 1099
Pu
bl
is
he
d 
on
 2
1 
D
ec
em
be
r 
20
18
. D
ow
nl
oa
de
d 
on
 1
0/
9/
20
20
 1
0:
40
:0
4 
A
M
. 
View Article Online
L. Moroni and A. Khademhosseini, J. Controlled Release,
2014, 187, 66–73.
72 K. Nartetamrongsutt and G. G. Chase, Polymer, 2013, 54,
2166–2173.
73 P. B. Bolno, D. Morgan, A. Wechsler and J. Y. Kresh, J. Am.
Coll. Surg., 2004, 199, 33.
74 J. Deshane, S. Chen, S. Caballero, A. Grochot-Przeczek,
H. Was, S. Li Calzi, R. Lach, T. D. Hock, B. Chen, N. Hill-
Kapturczak, G. P. Siegal, J. Dulak, A. Jozkowicz,
M. B. Grant and A. Agarwal, J. Exp. Med., 2007, 204, 605–
618.
75 Y. Ohki, FASEB J., 2005, 19(14), DOI: 10.1096/fj.04-3496fje.
Paper Biomaterials Science
1100 | Biomater. Sci., 2019, 7, 1088–1100 This journal is © The Royal Society of Chemistry 2019
Pu
bl
is
he
d 
on
 2
1 
D
ec
em
be
r 
20
18
. D
ow
nl
oa
de
d 
on
 1
0/
9/
20
20
 1
0:
40
:0
4 
A
M
. 
View Article Online
